CompletedPHASE1, PHASE2NCT02096510

Ultradian Subcutaneous Hydrocortisone Infusion in Addison Disease and Congenital Adrenal Hyperplasia

Studying Addison disease

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Haukeland University Hospital
Principal Investigator: Katerina Simunkova, MD, PhD
Universtity of Bergen
Intervention: Solu-Cortef(drug)
Enrollment: 8 enrolled
Eligibility: 18-65 years · All sexes
Timeline: 2014 – 2017

Study locations (1)

University Hospital Helse Bergen, Bergen, Norway

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02096510 on ClinicalTrials.gov

Other trials for Addison disease

Additional recruiting or active studies for the same condition.

RECRUITINGNCT06955286
Study on the Incidence of Adrenal Insufficiency After Surgery in Primary Aldosteronism Patients Concurrent With or Without Autonomous Cortisol Secretion
Qifu Li

See all trials for Addison disease →

← Back to all trials